Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Sokka who wrote (84184)	3/5/2024 2:50:11 PM
From: Tweets Boar Hog	1 Recommendation Recommended By ajtj99 Read Replies (3) \| Respond to of 97912

Nvax ... looks like the eagle has landed. Very bullish Biotech indices, new ATH's in the works. Nvax still has risk, but their biggest problems are in the rear view mirror. This will be an important year for them. As always we see but I am in. Latest CEO at Nvax seems to be a realist, give him good marks so far. And Nvax has some excellent products, in the market, awa in the chain. Tweets Nvax landed on a major 4 and 4.5 yr low, dead on. The weekly Rsi has popped up to mid tine, after going through that long dreadful down spin. I am a weekly chart lover. The confluence of this major longer term cycle low with the Rsi pattern is bullish. We C. What a game we play.